Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hyphens Pharma operates a commercial-stage business focused on distributing specialty pharmaceuticals, proprietary brands in dermatological care, supplements, medical devices, contrast media for radiological imaging, probiotics for gut health, and more across Southeast Asia. The company does not conduct drug discovery or clinical development but instead licenses/distributes approved products from global partners while also developing its own consumer healthcare brands such as Ceradan®, TDF®, Ocean Health®, CG210®. Recent partnerships have expanded their reach into new geographies with flagship brands like Ceradan® entering the Middle East market in collaboration with Cooper Pharma.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hyphens Pharma.